4503:TYO
Astellas Pharma Inc
¥2,501.00
arrow_downward
-0.68%(-17.00) 1D
Oct 28, 3:30:00 PM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4503...
Open
¥2,513
High
¥2,548
Low
¥2,496
Mkt. cap
4.53T
Avg. vol.
5.72M
Volume
5.21M
Dividend
3.12%
Quarterly dividend
¥20
Ex-dividend date
Sep 29, 2026
P/E ratio
12.28
52-wk high
¥2,717
52-wk low
¥1,558
EPS
¥204
Shares outstanding
1.92B
No. of employees
14K
Open
¥2,513
High
¥2,548
Low
¥2,496
Mkt. cap
4.53T
Avg. vol.
5.72M
Volume
5.21M
Dividend
3.12%
Quarterly dividend
¥20
Ex-dividend date
Sep 29, 2026
P/E ratio
12.28
52-wk high
¥2,717
52-wk low
¥1,558
EPS
¥204
Shares outstanding
1.92B
No. of employees
14K
News stories
From web sources and news partners
Investing.com
·
21 hours ago
Astellas secures option for Audax’s cancer drug DAX-044
Profile
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Astellas Pharma Inc
CEONaoki Okamura
Employees14.1K
FoundedApr 1, 2005
HeadquartersChuo City, Tokyo, Japan
SectorPharmaceutical industry
Websiteastellas.com